多中心注册分析:初始腹膜透析患者技术失败的中心特征关联
基于澳大利亚和新西兰透析与移植注册数据,纳入2004至2014年澳大利亚51个中心的9362例初始腹膜透析患者,采用Cox共享脆弱模型分析技术失败的中心及患者层面预测因素。技术失败率为0.35例/患者年(95%CI 0.34-0.36),中心间差异达7倍,主要与中心特征相关;腹膜透析患者比例较高(>29%)的中心技术失败风险较低(aHR 0.83,95%CI 0.73-0.94),而年新患者较少(<16例)及达到目标基线血磷患者比例较低(<40%)的中心风险较高。
要点
- 中心间技术失败率差异达7倍,主要归因于可改变的中心特征。
- 腹膜透析患者比例>29%的中心技术失败风险显著降低(aHR 0.83)。
- 年新患者<16例及目标血磷达标比例<40%的中心技术失败风险升高。
核心结论
- 澳大利亚腹膜透析中心间技术失败率差异显著,部分差异与可改变的中心特征相关。
研究设计与样本
- 基于澳大利亚和新西兰透析与移植注册的回顾性多中心注册分析,纳入2004至2014年澳大利亚51个中心的9362例初始腹膜透析患者,采用Cox共享脆弱模型评估技术失败预测因素。
主要发现
- 技术失败率为0.35例/患者年(95%CI 0.34-0.36),中心间差异达7倍。
- 腹膜透析患者比例>29%的中心技术失败风险较低(aHR 0.83,95%CI 0.73-0.94)。
- 年新患者<16例的中心技术失败风险较高(aHR 1.10,95%CI 1.00-1.21)。
- 达到目标基线血磷患者比例<40%的中心技术失败风险较高(aHR 1.15,95%CI 1.03-1.29)。
- 调整患者因素后中心间风险差异减少28%,再加入中心因素后额外减少53%。
关键数值与推荐
- 中心腹膜透析患者比例>29%对应技术失败aHR 0.83(95%CI 0.73-0.94)。
- 中心年新患者<16例对应技术失败aHR 1.10(95%CI 1.00-1.21)。
- 中心目标基线血磷达标比例<40%对应技术失败aHR 1.15(95%CI 1.03-1.29)。
临床怎么用
- 肾内科智能体可关注中心腹膜透析患者比例、年新患者数量及血磷达标率等可改变特征以优化技术失败风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Technique failure is a major limitation of peritoneal dialysis. Our study aimed to identify center- and patient-level predictors of peritoneal dialysis technique failure. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All patients on incident peritoneal dialysis in Australia from 2004 to 2014 were included in the study using data from the Australia and New Zealand Dialysis and Transplant Registry. Center- and patient-level characteristics associated with technique failure were evaluated using Cox shared frailty models. Death-censored technique failure and cause-specific technique failure were analyzed as secondary outcomes. RESULTS: The study included 9362 patients from 51 centers in Australia. The technique failure rate was 0.35 (95% confidence interval, 0.34 to 0.36) episodes per patient-year, with a sevenfold variation across centers that was mainly associated with center-level characteristics. Technique failure was significantly less likely in centers with larger proportions of patients treated with peritoneal dialysis (>29%; adjusted hazard ratio, 0.83; 95% confidence interval, 0.73 to 0.94) and more likely in smaller centers (<16 new patients per year; adjusted hazard ratio, 1.10; 95% confidence interval, 1.00 to 1.21) and centers with lower proportions of patients achieving target baseline serum phosphate levels (<40%; adjusted hazard ratio, 1.15; 95% confidence interval, 1.03 to 1.29). Similar results were observed for death-censored technique failure, except that center target phosphate achievement was not significantly associated. Technique failure due to infection, social reasons, mechanical causes, or death was variably associated with center size, proportion of patients on peritoneal dialysis, and/or target phosphate achievement, automated peritoneal dialysis exposure, icodextrin use, and antifungal use. The variation of hazards of technique failure across centers was reduced by 28% after adjusting for patient-specific factors and an additional 53% after adding center-specific factors. CONCLUSIONS: Technique failure varies widely across centers in Australia. A significant proportion of this variation is related to potentially modifiable center characteristics, including peritoneal dialysis center size, proportion of patients on peritoneal dialysis, and proportion of patients on peritoneal dialysis achieving target phosphate level.
引用
- Htay H, Cho Y, Pascoe EM, et al. Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis. Clin J Am Soc Nephrol. 2017. PMID: 28637862. doi:10.2215/CJN.12321216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。